Whitestown, IN, United States of America

Leonard Larry Winneroski, Ii

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leonard Larry Winneroski, Ii. Retrieved from https://idiyas.com/inventor/leonard-larry-winneroski-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leonard Larry Winneroski, II: Innovator in ATR Antagonists

Introduction

Leonard Larry Winneroski, II is a notable inventor based in Whitestown, Indiana. He has made significant contributions to the field of pharmacology, particularly through his work on ATR antagonists. His innovative approach has led to the development of new compounds that hold promise for various therapeutic applications.

Latest Patents

Winneroski holds a patent for ATR antagonists and their uses. This invention provides certain piperidine compounds as ATR antagonists, specifically compounds of formula (I). This patent represents a crucial advancement in the search for effective treatments in related medical fields.

Career Highlights

Leonard Larry Winneroski, II is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His work at Eli Lilly has allowed him to focus on developing new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout his career, Winneroski has collaborated with esteemed colleagues, including Thomas James Beauchamp and Zhaogen Chen. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Leonard Larry Winneroski, II is a distinguished inventor whose work on ATR antagonists has the potential to impact the pharmaceutical industry significantly. His contributions reflect a dedication to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…